X0306 4 2023-02-27 0 0001420800 Enovis CORP ENOV 0001205249 PRYOR DANIEL A 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 0 1 0 0 EVP, Strategy & Business Dev. Common stock, par value $0.001 2023-02-27 4 A 0 10341 0.00 A 83853 D Common stock, par value $0.001 2023-02-27 4 S 0 5716 56.08 D 78137 D Common stock, par value $0.001 2023-02-28 4 A 0 7862 0.00 A 85999 D Common stock, par value $0.001 2023-02-28 4 A 0 24190 0.00 A 110189 D Common stock, par value $0.001 932 I By 401k plan Common stock, par value $0.001 333 I By trust for daughter Common stock, par value $0.001 333 I By trust for daughter Common stock, par value $0.001 333 I By trust for son Employee Stock Option (right to buy) 57.62 2023-02-28 4 A 0 18642 0.00 A 2030-02-27 Common stock, par value $0.001 18642 18642 D Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. The option vests in three equal annual installments beginning on the first anniversary of the grant date. /s/ Brian P. Hanigan, attorney-in-fact 2023-03-01